DJ Biogen Inc. Stock Rises Wednesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ inched 0.73% higher to $157.46 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.82% to 6,084.19 and the Dow Jones Industrial Average falling 0.22% to 44,148.56.
The stock's rise snapped a four-day losing streak.
Biogen Inc. closed $110.84 below its 52-week high ($268.30), which the company reached on January 3rd.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.74% to $146.64 and Pfizer Inc. $(PFE)$ fell 1.33% to $25.23.
Trading volume (1.4 M) remained 103,386 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 11, 2024 17:07 ET (22:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments